Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention ...

The CDC now says everyone 50 to 64 years old should get a pneumococcal vaccine to help protect against serious illnesses like pneumonia, meningitis, and bloodstream infections.

The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

The Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) is recommending that the age for pneumococcal vaccination be lowered from 65 to 50 years.

As the weather starts to cool down and we spend more time gathered together indoors, the risk of contracting an illness rises ...

Each year, the U.S. sees roughly 30,000 cases of invasive pneumococcal disease, which includes blood infections, brain and ...